Skip to main content
Log in

The impact of dosing regimen on HRQOL in breast cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Buijs C, Rodenhuis S, Seynaeve CM, Van Hoesel QGCM, van der Wall E, Smit WJM, Nooij MA, Voest E, Hupperets P, TenVergert EM, van Tinteren H, Willemse PHB, Mouritis MJE, Aaronson NK, Post WJ, de Vries EGE.Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality life. Journal of Clinical Oncology 25: 5403-5409, No. 34, 1 Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The impact of dosing regimen on HRQOL in breast cancer. Pharmacoecon. Outcomes News 543, 10 (2007). https://doi.org/10.2165/00151234-200705430-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705430-00027

Keywords

Navigation